585 related articles for article (PubMed ID: 18684438)
1. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives.
Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a cyclomaltoheptaose-4-hydroxybiphenyl inclusion complex.
Wang EJ; Yan Z; Cai J
Carbohydr Res; 2007 Aug; 342(11):1530-4. PubMed ID: 17509545
[TBL] [Abstract][Full Text] [Related]
3. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
4. Crystal form III of beta-cyclodextrin-ethanol inclusion complex: layer-type structure with dimeric motif.
Aree T; Chaichit N
Carbohydr Res; 2008 Sep; 343(13):2285-91. PubMed ID: 18490008
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a new cyclomaltoheptaose hydrate: beta-cyclodextrin.7.5H2O.
Li JY; Sun DF; Hao AY; Sun HY; Shen J
Carbohydr Res; 2010 Mar; 345(5):685-8. PubMed ID: 20163791
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Yang ZX; Chen Y; Liu Y
Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of cyclomaltoheptaose (beta-cyclodextrin) complexes with p-aminobenzoic acid and o-aminobenzoic acid.
Zhang Y; Yu S; Bao F
Carbohydr Res; 2008 Sep; 343(14):2504-8. PubMed ID: 18675404
[TBL] [Abstract][Full Text] [Related]
8. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
9. Characterization of aspartame-cyclodextrin complexation.
Sohajda T; Béni S; Varga E; Iványi R; Rácz A; Szente L; Noszál B
J Pharm Biomed Anal; 2009 Dec; 50(5):737-45. PubMed ID: 19586735
[TBL] [Abstract][Full Text] [Related]
10. A convenient preparation of 6-oligo(lactic acid)cyclomaltoheptaose as kinetically degradable derivative for controlled release of amoxicillin.
Shen J; Hao A; Du G; Zhang H; Sun H
Carbohydr Res; 2008 Oct; 343(15):2517-22. PubMed ID: 18619585
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of the 1:1 inclusion complex of beta-cyclodextrin with benzamide.
Wang EJ; Lian ZX; Cai J
Carbohydr Res; 2007 Apr; 342(5):767-71. PubMed ID: 17210149
[TBL] [Abstract][Full Text] [Related]
12. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
13. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
14. Crystal and molecular structure of beta-cyclodextrins functionalized with the anti-inflammatory drug Etodolac.
Puglisi A; Rizzarelli E; Vecchio G; Iacovino R; Benedetti E; Pedone C; Saviano M
Biopolymers; 2009 Dec; 91(12):1227-35. PubMed ID: 19365815
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic investigations and crystal structure from synchrotron powder data of the inclusion complex of beta-cyclodextrin with atenolol.
Borodi G; Bratu I; Dragan F; Peschar R; Helmholdt RB; Hernanz A
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Oct; 70(5):1041-8. PubMed ID: 18061532
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of inclusion complexes of a cationic beta-cyclodextrin polymer with butylparaben or triclosan.
Qian L; Guan Y; Xiao H
Int J Pharm; 2008 Jun; 357(1-2):244-51. PubMed ID: 18294789
[TBL] [Abstract][Full Text] [Related]
17. Crystal and molecular structure of octakis(6-bromo-6-deoxy)-gamma-cyclodextrin. A novel stacking of a distorted macrocycle.
Paulidou A; Giastas P; Mourtzis N; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2007 Aug; 342(11):1519-24. PubMed ID: 17555730
[TBL] [Abstract][Full Text] [Related]
18. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin.
Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C
Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438
[TBL] [Abstract][Full Text] [Related]
20. Validating a strategy for molecular dynamics simulations of cyclodextrin inclusion complexes through single-crystal X-ray and NMR experimental data: a case study.
Raffaini G; Ganazzoli F; Malpezzi L; Fuganti C; Fronza G; Panzeri W; Mele A
J Phys Chem B; 2009 Jul; 113(27):9110-22. PubMed ID: 19526998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
